☰

Lavakumar Karyampudi, Ph.D. - Publications

Affiliations: 
2007 Indiana State University, Evansville, IN, United States 
Area:
Immunology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Knutson KL, Block MS, Norton N, Erskine CL, Hobday TJ, Dietz AB, Padley D, Gustafson MP, Puglisi-Knutson D, Mangskau TK, Chumsri S, Dueck AC, Karyampudi L, Wilson G, Degnim AC. Rapid generation of sustainable HER2-specific T cell immunity in HER2 breast cancer patients using a degenerate HLA class II epitope vaccine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31757875 DOI: 10.1158/1078-0432.Ccr-19-2123  0.475
2017 Lamichhane P, Karyampudi L, Shreeder B, Krempski J, Bahr D, Daum J, Kalli KR, Goode EL, Block MS, Cannon MJ, Knutson KL. IL-10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer. Cancer Research. PMID 28993412 DOI: 10.1158/0008-5472.Can-17-0740  0.457
2016 Knutson KL, Karyampudi L, Lamichhane P, Preston C. Retraction Note: Targeted immune therapy of ovarian cancer. Cancer Metastasis Reviews. PMID 27239671 DOI: 10.1007/S10555-016-9627-Z  0.381
2016 Lamichhane P, Karyampudi L, Shreeder B, Krempski J, Bahr D, Block M, Knutson K. Abstract B66: Blockade of PD-1 signaling in tumor-associated dendritic cells results in compensatory IL-10 release maintaining immune suppression in ovarian cancer microenvironments. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B66  0.471
2015 Karyampudi L, Lamichhane P, Krempski J, Kalli KR, Behrens MD, Vargas DM, Hartmann LC, Janco JM, Dong H, Hedin KE, Dietz AB, Goode EL, Knutson KL. PD-1 blunts the function of ovarian tumor-infiltrating dendritic cells by inactivating NF-KappaB. Cancer Research. PMID 26567141 DOI: 10.1158/0008-5472.Can-15-0748  0.489
2015 Tran Janco JM, Lamichhane P, Karyampudi L, Knutson KL. Tumor-infiltrating dendritic cells in cancer pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 194: 2985-91. PMID 25795789 DOI: 10.4049/Jimmunol.1403134  0.488
2015 Knutson KL, Karyampudi L, Lamichhane P, Preston C. Targeted immune therapy of ovarian cancer. Cancer Metastasis Reviews. 34: 53-74. PMID 25544369 DOI: 10.1007/S10555-014-9540-2  0.473
2015 Karyampudi L, Krempski J, Lamichhane P, Kalli KR, Behrens MD, Vargas DM, Hartmann LC, Hedin KE, Goode EL, Knutson KL. Abstract POSTER-THER-1418: PD-1 mediated paralysis of ovarian cancer infiltrating dendritic cells Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Ther-1418  0.511
2014 Karyampudi L, Lamichhane P, Scheid AD, Kalli KR, Shreeder B, Krempski JW, Behrens MD, Knutson KL. Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody. Cancer Research. 74: 2974-85. PMID 24728077 DOI: 10.1158/0008-5472.Can-13-2564  0.562
2013 Pavelko KD, Bell MP, Karyampudi L, Hansen MJ, Allen KS, Knutson KL, Pease LR. The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1087-95. PMID 23568262 DOI: 10.1038/Mt.2013.52  0.449
2011 Krempski J, Karyampudi L, Behrens MD, Erskine CL, Hartmann L, Dong H, Goode EL, Kalli KR, Knutson KL. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. Journal of Immunology (Baltimore, Md. : 1950). 186: 6905-13. PMID 21551365 DOI: 10.4049/Jimmunol.1100274  0.556
2010 Karyampudi L, Knutson KL. Antibodies in cancer immunotherapy. Cancer Biomarkers : Section a of Disease Markers. 6: 291-305. PMID 20938089 DOI: 10.3233/Cbm-2009-0141  0.37
2010 Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL. A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 825-34. PMID 20103660 DOI: 10.1158/1078-0432.Ccr-09-2781  0.433
2010 Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, et al. Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen. Cancer Immunology, Immunotherapy : Cii. 59: 161-71. PMID 19621224 DOI: 10.1007/S00262-009-0738-Z  0.511
2008 Karyampudi L, Ghosh SK. Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma. Cellular Immunology. 254: 74-80. PMID 18715553 DOI: 10.1016/J.Cellimm.2008.07.003  0.487
Show low-probability matches.